Sign In
Buy AMGN
$345.60
+7.38 (+2.18%)
At Close: Jun 04, 2026
Amgen Delivers a Q1 Earnings Beat
06:19pm, Friday, 03'rd May 2024
On the earnings front, the biotech beat estimates with non-GAAP EPS of $3.96 vs. the expected $3.88.
Why Amgen Stock Zoomed Nearly 12% Higher Today
06:15pm, Friday, 03'rd May 2024
The pharmaceutical sector mainstay published its first-quarter results. These beat on both the top and bottom lines.
Amgen (AMGN) Q1 Earnings Top, Stock Up on Obesity Drug Update
12:51pm, Friday, 03'rd May 2024
Amgen (AMGN) beats first-quarter 2024 estimates for earnings and sales. Amgen is "very encouraged" by interim data from the phase II study on obesity candidate MariTide.
Amgen (AMGN) Sales Higher After Obesity Drug Results
12:37pm, Friday, 03'rd May 2024
Amgen (AMGN) sales are higher after early results from a study of an obesity drug. Renita Young discusses this as the Amgen CEO is “very encouraged” by the results of the obesity drug study.
Amgen shares soar on obesity drug optimism
09:51am, Friday, 03'rd May 2024
Amgen Inc (NASDAQ:AMGN, ETR:AMG) shares gained almost 13% at about $314 in early trade on Friday after the drugmaker said it was “very encouraged” by interim trial data for its experimental weight
Dow Jones Today: Stock Futures Higher Ahead of Jobs Data; Apple, Amgen Surging
08:45am, Friday, 03'rd May 2024
U.S. stock futures were solidly higher Friday morning as investors digested a slew of earnings reports and awaited the monthly U.S. employment report.
Here are the moves to make to counter range-bound, choppy markets, says Goldman Sachs
08:38am, Friday, 03'rd May 2024
Friday stock-index futures are looking chipper, given an extra boost by a nonfarm payrolls report that pointed to a cooling labor market and lower wage inflation.
Novo Nordisk drops 5% after rival Amgen teases weight-loss drug data
06:36am, Friday, 03'rd May 2024
Shares in Danish drugmaker Novo Nordisk dropped as much as 5.3% on Friday, set for their biggest one-day fall since August 2022, after rival Amgen said it was encouraged by interim trial data on its e
Amgen shares jump after teasing 'encouraging' weight loss data
05:42am, Friday, 03'rd May 2024
U.S. drugmaker Amgen's shares jumped 13% to $316.26 premarket on Friday as the company teased encouraging data for its experimental obesity drug, igniting investor hopes but leaving Wall Street frustr
Amgen Stock Jumps on Obesity Drug Optimism. What Comes Next.
05:12am, Friday, 03'rd May 2024
The company is trying to carve a niche in a rapidly growing obesity-drug market that's currently dominated by Eli Lilly and Novo Nordisk.
Amgen Stock Surges After Q1 Earnings Beat, 'Encouraging' Weight-Loss Drug Update
10:25pm, Thursday, 02'nd May 2024
Amgen (AMGN) shares surged more than 14% in extended-hours trading on Thursday after the biopharmaceutical giant posted quarterly earnings that came in ahead of Wall Street expectations and provided a
Amgen, Inc. (AMGN) Q1 2024 Earnings Call Transcript
09:12pm, Thursday, 02'nd May 2024
Amgen, Inc. (NASDAQ:AMGN ) Q1 2024 Earnings Conference Call May 2, 2024 4:30 PM ET Company Participants Justin Claeys - VP, IR Robert Bradway - Chairman, CEO & President James Bradner - EVP, Research
Here's What Key Metrics Tell Us About Amgen (AMGN) Q1 Earnings
07:00pm, Thursday, 02'nd May 2024
The headline numbers for Amgen (AMGN) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates
Amgen expects data from weight-loss drug trial later this year
05:21pm, Thursday, 02'nd May 2024
Shares of Amgen Inc. rallied more than 11% in the extended session Thursday after the drugmaker posted adjusted earnings above expectations and said that plans for further trials for its weight-loss d
Amgen scraps experimental weight loss pill, moves forward with injection
05:00pm, Thursday, 02'nd May 2024
Amgen is among several drugmakers racing to join the red-hot weight loss drug space dominated by Novo Nordisk and Eli Lilly.
